Centerline Biomedical, Inc. was founded in 2014 as a spinoff of the Cleveland Clinic to commercialize our innovative vascular navigation technology. With a research, development, and design history rooted in the Clinic's world-class Lerner Research Institute's Heart and Vascular Institute, the IOPS™ platform can be further used for predictive modeling, clinical decision support, global healthcare analytics and the education and training of future surgeons and interventionists.
Date |
Amount |
Type |
Investors |
Valuation |
---|---|---|---|---|
03/10/20 | $10,000,000 | Venture | ||
06/27/22 | $33,000,000 | Series B |
Cleveland Clinic![]() G2 Group Ventures GE Healthcare JobsOhio JumpStart Ventures RIK Enterprises | undisclosed |